Synergy Pharmaceuticals Inc said its experimental once-daily tablet, plecanatide, met the main goal of a late-stage study on irritable bowel … Continue reading
The post Synergy Pharma’s irritable bowel drug succeeds in key study appeared first on News - Breaking News Updates | ScoopRocket News.